About Klinikum der Universität zu Köln, Klinik I für Innere Medizin
Clinical Trials at Klinikum der Universität zu Köln, Klinik I für Innere Medizin
During the past decade, Klinikum der Universität zu Köln, Klinik I für Innere Medizin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Spectrum Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Klinikum der Universität zu Köln, Klinik I für Innere Medizin
According to Clinical.Site data, the most researched conditions in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin" are
"Acute Myeloid Leukemia" (1 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "HIV I Infection" (1 trials), "HIV-1 Infection" (1 trials) and "Large Cell Neuroendocrine Carcinoma of the Lung" (1 trials). Many other conditions were trialed in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum der Universität zu Köln, Klinik I für Innere Medizin
Most popular intervention types in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Conventional Vincristine" (1 trials), "Lenalidomide" (1 trials), "Lenalidomide placebo" (1 trials) and "Liposomal Vincristine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum der Universität zu Köln, Klinik I für Innere Medizin
The vast majority of trials in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum der Universität zu Köln, Klinik I für Innere Medizin
Currently, there are NaN active trials in "Klinikum der Universität zu Köln, Klinik I für Innere Medizin".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum der Universität zu Köln, Klinik I für Innere Medizin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der Universität zu Köln, Klinik I für Innere Medizin, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".